FindTrial
Sign In

Effect of laparoscopic hepatectomy and conservative therapy for hepatic hemangiomas in adults: a cohort study

Effect of laparoscopic hepatectomy and conservative therapy for hepatic hemangiomas in adults: a cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INC-17012143
Enrollment
Unknown
Registered
2017-07-26
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemangiomas of liver in adults

Interventions

Group B:laparoscopic hepatectomy
Group A:Observation

Sponsors

Nanjing Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Hemangiomoas of liver diagnosed by Type B ultrasound and enhancement Computer tomography or Magnetic Resonance Iamging; 2. Diameter: more than 5 cm in left liver or more than 8 cm in right liver under surface; 3. No contradiction for laparoscopic surgery; 4. Adults from 18 to 70 years

Exclusion criteria

Exclusion criteria: 1. Patients who do not sign informed consent form; 2. Patients with other occupying lesion in liver; 3. with pregancy; 4. Intolerent to operation because of organ dysfunction; 5. Can't undergo laparoscopic procedure because of past procedure in abdomin or other causes.

Design outcomes

Primary

MeasureTime frame
Mortality;Symptom relief rate;Medical cost;Qualification of life;Morbidity;—

Countries

China

Contacts

Public ContactDecai Yu

the Affiliated Drum Tower Hospital, Medical School of Nanjing University

dryudecai@qq.com+86 13016966715

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026